Skip to main content
Premium Trial:

Request an Annual Quote

Blind No More?

FDA has given biotech company Advanced Cell Technology the go-ahead to test a treatment for macular degeneration using human embryonic stem cells in a clinical trial, says Jennifer Welsh at the 80beats blog. Researchers at Advanced Cell Technology suggest that implanting hESCs in these patients could end retinal pigment epithelial cell death and reverse blindness; using this approach, the team saw improved vision in rats, Welsh says. The first trial will include 12 patients to determine the safety and tolerability of transplanting hESCs for this purpose, she adds. Advanced Cell Technology had also previously been approved to conduct a similar trial on patients with a rare juvenile form of the disease.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.